Companies

Avidity Biosciences, Inc.

RNAM, RNA · CIK 0001599901 · operating

$14.98+1.56%Last updated Mar 2, 8:48 PM

Key Statistics

Valuation

Market Cap$2.30B
P/E
Fwd P/E-3.70
PEG
P/S
P/B1.34
EV/EBITDA
EV/Rev

Profitability

Gross Margin
Op. Margin-3977.30%
Net Margin-3650.39%
ROE-40.54%
ROA-34.96%
FCF Margin-3539.11%

Financial Health

Current Ratio9.20
Debt/Equity0.16
Free Cash Flow-$663.76M
Div. Yield

Growth & Other

Revenue Growth72.11%
EPS Growth-71.97%
Beta
52W High$15.93
52W Low$13.06

About Avidity Biosciences, Inc.

Avidity Biosciences, Inc. (RNA) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $11.2 billion, Avidity Biosciences, Inc. is a large-cap company. The stock currently trades at $14.98, up 1.56% today, with a 52-week range of $21.51–$73.06.

Earnings Per Share (Annual · SEC XBRL)

Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.

Fiscal YearEPS DilutedEPS BasicYoY
2025$-4.97$-4.97-72.0%
2024$-2.89$-2.89+0.7%
2023$-2.91$-2.91+12.9%
2022$-3.34$-3.34
2021
2020

Annual Reports (10-K) · 6 filings

Report DateFiledAccession Number
2025-12-312026-02-230001599901-26-000031SEC ↗
2024-12-312025-02-270001599901-25-000059SEC ↗
2023-12-312024-02-280001599901-24-000025SEC ↗
2022-12-312023-02-280001599901-23-000009SEC ↗
2021-12-312022-03-010001564590-22-008049SEC ↗
2020-12-312021-03-150001564590-21-013157SEC ↗